165 related articles for article (PubMed ID: 33895864)
1. Drug-drug interactions between vitamin K antagonists and statins: a systematic review.
Engell AE; Svendsen ALO; Lind BS; Stage TB; Hellfritzsch M; Pottegård A
Eur J Clin Pharmacol; 2021 Oct; 77(10):1435-1441. PubMed ID: 33895864
[TBL] [Abstract][Full Text] [Related]
2. Statin use decreases coagulation in users of vitamin K antagonists.
van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.
Pottegård A; dePont Christensen R; Wang SV; Gagne JJ; Larsen TB; Hallas J
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1160-7. PubMed ID: 25250949
[TBL] [Abstract][Full Text] [Related]
4. Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study.
Stage TB; Pottegård A; Henriksen DP; Christensen MM; Højlund K; Brøsen K; Damkier P
J Thromb Haemost; 2016 Jan; 14(1):129-33. PubMed ID: 26559049
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interaction between warfarin and statins: A Danish cohort study.
Engell AE; Svendsen ALO; Lind BS; Andersen CL; Andersen JS; Willadsen TG; Persson F; Pottegård A
Br J Clin Pharmacol; 2021 Feb; 87(2):694-699. PubMed ID: 32533893
[TBL] [Abstract][Full Text] [Related]
6. The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study.
Andersson ML; Mannheimer B; Lindh JD
Eur J Clin Pharmacol; 2019 Oct; 75(10):1387-1392. PubMed ID: 31201436
[TBL] [Abstract][Full Text] [Related]
7. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis.
Caldeira D; Costa J; Barra M; Pinto FJ; Ferreira JJ
Thromb Res; 2015 Jan; 135(1):58-61. PubMed ID: 25456003
[TBL] [Abstract][Full Text] [Related]
8. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
[TBL] [Abstract][Full Text] [Related]
9. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
[TBL] [Abstract][Full Text] [Related]
10. A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment.
Riva N; Vella K; Meli S; Hickey K; Zammit D; Calamatta C; Makris M; Kitchen S; Ageno W; Gatt A
Int J Lab Hematol; 2017 Oct; 39(5):482-488. PubMed ID: 28500649
[TBL] [Abstract][Full Text] [Related]
11. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective.
Gatt A; Chen D; Pruthi RK; Kamath PS; Leise MD; Ashrani AA; Nichols WL; He R
Semin Thromb Hemost; 2014 Nov; 40(8):845-51. PubMed ID: 25393635
[TBL] [Abstract][Full Text] [Related]
12. Approaches to optimal dosing of vitamin K antagonists.
Witt DM
Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
[TBL] [Abstract][Full Text] [Related]
13. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
[TBL] [Abstract][Full Text] [Related]
14. Interaction of vitamin K antagonists and trimethoprim-sulfamethoxazole: ignore at your patient's risk.
Hale SF; Lesar TS
Drug Metabol Drug Interact; 2014; 29(1):53-60. PubMed ID: 24231121
[TBL] [Abstract][Full Text] [Related]
15. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.
Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM
Circ Cardiovasc Interv; 2019 Feb; 12(2):e007124. PubMed ID: 30704287
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
Sørensen B; Johansen P; Nielsen GL; Sørensen JC; Ingerslev J
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):469-77. PubMed ID: 12851533
[TBL] [Abstract][Full Text] [Related]
17. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
Moffat KA; Lewis CW
Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
[TBL] [Abstract][Full Text] [Related]
20. Statin treatment and the risk of recurrent pulmonary embolism.
Biere-Rafi S; Hutten BA; Squizzato A; Ageno W; Souverein PC; de Boer A; Gerdes VE; Büller HR; Kamphuisen PW
Eur Heart J; 2013 Jun; 34(24):1800-6. PubMed ID: 23396492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
